MEXILETINE HYDROCHLORIDE (MEXILETINE HYDROCHLORIDE) — FDA Approval ANDA213500 (CROSSMEDIKA SA)
MEXILETINE HYDROCHLORIDE (MEXILETINE HYDROCHLORIDE) — FDA Approval ANDA213500 (CROSSMEDIKA SA) is one of 9,000 drug approvals in the DrugApprovals dataset. Key details — Brand name: MEXILETINE HYDROCHLORIDE; Active ingredients: MEXILETINE HYDROCHLORIDE; Application number: ANDA213500.
| Brand name | MEXILETINE HYDROCHLORIDE |
|---|---|
| Active ingredients | MEXILETINE HYDROCHLORIDE |
| Application number | ANDA213500 |
| Sponsor | CROSSMEDIKA SA |
| Dosage form | CAPSULE |
| Route | ORAL |
| Marketing status | Prescription |
| Products in application | 3 |
| First approval date | 20200722 |
| Source | openFDA Drugs@FDA |
$1499/mo
Try DrugApprovals →